 | Up a level |
Auer, Reto; Schoeni, Anna; Humair, Jean-Paul; Jacot-Sadowski, Isabelle; Berlin, Ivan; Stuber, Mirah J.; Haller, Moa Lina; Casagrande Tango, Rodrigo; Frei, Anna; Strassmann, Alexandra; Bruggmann, Philip; Baty, Florent; Brutsche, Martin; Tal, Kali; Baggio, Stéphanie; Jakob, Julian; Sambiagio, Nicolas; Hopf, Nancy B.; Feller, Martin; Rodondi, Nicolas; ... (2024). Electronic Nicotine-Delivery Systems for Smoking Cessation. New England journal of medicine NEJM, 390(7), pp. 601-610. Massachusetts Medical Society MMS 10.1056/NEJMoa2308815
Hovaguimian, Frédérique; Kouyos, Roger D; Kusejko, Katharina; Schmidt, Axel J; Tarr, Philip E; Bernasconi, Enos; Braun, Dominique L; Calmy, Alexandra; Notter, Julia; Stoeckle, Marcel; Surial, Bernard; Christinet, Vanessa; Darling, Katharine E A; Depmeier, Carsten; Läuchli, Severin; Reinacher, Matthias; Rasi, Manuela; Nicca, Dunja; Bruggmann, Philip; Haerry, David; ... (2024). Incidence of sexually transmitted infections and association with behavioural factors: Time-to-event analysis of a large pre-exposure prophylaxis (PrEP) cohort. HIV medicine, 25(1), pp. 117-128. Wiley 10.1111/hiv.13543
Winter, Babette L; Hovaguimian, Frédérique; Kouyos, Roger D; Schmidt, Axel Jeremias; Bernasconi, Enos; Braun, Dominique L; Calmy, Alexandra; Notter, Julia; Stoeckle, Marcel; Surial, Bernard; Christinet, Vanessa; Cavassini, Matthias; Depmeier, Carsten; Läuchli, Severin; Boffi El Amari, Emmanuelle; Reinacher, Matthias; Rasi, Manuela; Bruggmann, Philip; Haerry, David; Bize, Raphaël; ... (2022). Changes in mental and sexual health among MSM using HIV pre-exposure prophylaxis during the SARS-CoV-2 pandemic: longitudinal analysis of the SwissPrEPared cohort study. Swiss medical weekly, 152, w30192. EMH Schweizerischer Ärzteverlag 10.4414/smw.2022.w30192
Bihl, Florian; Bruggmann, Philip; Castro Batänjer, Erika; Dufour, Jean-François; Lavanchy, Daniel; Müllhaupt, Beat; Negro, Francesco; Razavi, Homie; Scheidegger, Claude; Semela, David; Semmo, Nasser; Blach, Sarah (2022). HCV disease burden and population segments in Switzerland. Liver international, 42(2), pp. 330-339. Wiley 10.1111/liv.15111
Bregenzer, Andrea; Bruggmann, Philip; Castro, Erika; Moriggia, Alberto; Rothen, Madeleine; Thurnheer, Maria Christine; Vernazza, Pietro; Scheidegger, Claude (2021). Hepatitis C virus elimination in Swiss opioid agonist therapy programmes - the SAMMSU cohort. Swiss medical weekly, 151, w20460. EMH Media 10.4414/smw.2021.20460
Cunningham, Evan B; Hajarizadeh, Behzad; Amin, Janaki; Litwin, Alain H; Gane, Edward; Cooper, Curtis; Lacombe, Karine; Hellard, Margaret; Read, Phillip; Powis, Jeff; Dalgard, Olav; Bruneau, Julie; Matthews, Gail V; Feld, Jordan J; Dillon, John F; Shaw, David; Bruggmann, Philip; Conway, Brian; Fraser, Chris; Marks, Philippa; ... (2020). Adherence to Once-daily and Twice-daily Direct-acting Antiviral Therapy for Hepatitis C Infection Among People With Recent Injection Drug Use or Current Opioid Agonist Therapy. Clinical infectious diseases, 71(7), e115-e124. Oxford University Press 10.1093/cid/ciz1089
Kusejko, Katharina; Marzel, Alex; Nguyen, Huyen; Chaudron, Sandra E; Bachmann, Nadine; Weber, Rainer; Bruggmann, Philip; Roth, Jan A; Bernasconi, Enos; Calmy, Alexandra; Cavassini, Matthias; Bregenzer, Andrea; Böni, Jürg; Yerly, Sabine; Klimkait, Thomas; Perreau, Matthieu; Walti, Laura N.; Günthard, Huldrych F; Kouyos, Roger D (2020). Differences in social and mental well-being of long-term survivors among people who inject drugs and other participants in the Swiss HIV Cohort Study: 1980-2018. Antiviral therapy, 25(1), pp. 43-54. International Medical Press 10.3851/IMP3347
Cunningham, Evan B; Amin, Janaki; Feld, Jordan J; Bruneau, Julie; Dalgard, Olav; Powis, Jeff; Hellard, Margaret; Cooper, Curtis; Read, Phillip; Conway, Brian; Dunlop, Adrian J; Norton, Briana; Litwin, Alain H; Hajarizadeh, Behzad; Thurnheer Zürcher, Maria Christine; Dillon, John F; Weltman, Martin; Shaw, David; Bruggmann, Philip; Gane, Edward; ... (2018). Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study. International journal of drug policy, 62, pp. 14-23. Elsevier 10.1016/j.drugpo.2018.08.013
Marzel, Alex; Kusejko, Katharina; Weber, Rainer; Bruggmann, Philip; Rauch, Andri; Roth, Jan A; Bernasconi, Enos; Calmy, Alexandra; Cavassini, Matthias; Hoffmann, Matthias; Böni, Jürg; Yerly, Sabine; Klimkait, Thomas; Perreau, Matthieu; Günthard, Huldrych F; Kouyos, Roger D (2018). The Cumulative Impact of Harm Reduction on the Swiss HIV Epidemic: Cohort Study, Mathematical Model, and Phylogenetic Analysis. Open Forum Infectious Diseases, 5(5), ofy078. Oxford University Press 10.1093/ofid/ofy078
Grebely, Jason; Dalgard, Olav; Conway, Brian; Cunningham, Evan B; Bruggmann, Philip; Hajarizadeh, Behzad; Amin, Janaki; Bruneau, Julie; Hellard, Margaret; Litwin, Alain H; Marks, Philippa; Quiene, Sophie; Siriragavan, Sharmila; Applegate, Tanya L; Swan, Tracy; Byrne, Jude; Lacalamita, Melanie; Dunlop, Adrian; Matthews, Gail V; Powis, Jeff; ... (2018). Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial. The lancet. Gastroenterology & hepatology, 3(3), pp. 153-161. Elsevier 10.1016/S2468-1253(17)30404-1
Bruggmann, Philip; Blach, Sarah; Deltenre, Pierre; Fehr, Jan; Kouyos, Roger; Lavanchy, Daniel; Müllhaupt, Beat; Rauch, Andri; Razavi, Homie; Schmid, Patrick; Semela, David; Stoeckle, Marcel; Negro, Franco (2017). Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030. Swiss medical weekly, 147(w14543), w14543. EMH Schweizerischer Ärzteverlag 10.4414/smw.2017.14543
Grebely, Jason; Dalgard, Olav; Cunningham, Evan B; Hajarizadeh, Behzad; Foster, Graham R; Bruggmann, Philip; Conway, Brian; Backmund, Markus; Robaeys, Geert; Swan, Tracy; Amin, Janaki; Marks, Philippa S; Quiene, Sophie; Applegate, Tanya L; Weltman, Martin; Shaw, David; Dunlop, Adrian; Hellard, Margaret; Bruneau, Julie; Midgard, Håvard; ... (2017). Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study. The international journal of drug policy, 47, pp. 177-186. Elsevier 10.1016/j.drugpo.2017.05.020
Cunningham, Evan B; Hajarizadeh, Behzad; Dalgard, Olav; Amin, Janaki; Hellard, Margaret; Foster, Graham R; Bruggmann, Philip; Conway, Brian; Backmund, Markus; Robaeys, Geert; Swan, Tracy; Marks, Philippa S; Quiene, Sophie; Applegate, Tanya L; Weltman, Martin; Shaw, David; Dunlop, Adrian; Bruneau, Julie; Midgard, Håvard; Bourgeois, Stefan; ... (2017). Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study. BMC infectious diseases, 17(1), p. 420. BioMed Central 10.1186/s12879-017-2517-3
Wandeler, Gilles; Dufour, Jean-François; Bruggmann, Philip; Rauch, Andri (2015). Hepatitis C: a changing epidemic. Swiss medical weekly, 145, w14093. EMH Schweizerischer Ärzteverlag 10.4414/smw.2015.14093
Fretz, Rainer; Negro, Francesco; Bruggmann, Philip; Lavanchy, Daniel; De Gottardi, Andrea; Pache, Isabelle; Masserey Spicher, Virginie; Cerny, Andreas (2013). Hepatitis B and C in Switzerland - healthcare provider initiated testing for chronic hepatitis B and C infection. Swiss medical weekly, 143, w13793. EMH Schweizerischer Ärzteverlag 10.4414/smw.2013.13793
Witteck, Andrea; Schmid, Patrick; Hensel-Koch, Katharina; Thurnheer, Maria C; Bruggmann, Philip; Vernazza, Pietro; Swiss Hepatitis C and HIV Cohort Studies, (2011). Management of hepatitis C virus (HCV) infection in drug substitution programs. Swiss medical weekly, 141, w13193. Muttenz: EMH Schweizerischer Ärzteverlag 10.4414/smw.2011.13193
